NOVARTIS AG Received a Patent for Inhibiting the Activity of BCR-ABL1 and Mutants
NOVARTIS AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. The disease focus areas of Novartis include Cancer, […]
Blockchain and Patent Law Research
NOVARTIS AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. The disease focus areas of Novartis include Cancer, […]